MORBITIME 400
MRP: 3,150
Packaging: 10x10
Pack Type: tablet
Composition:
Non-Invasive Travelers' Diarrhea, Hepatic Encephalopathy
Indication:
Non-Invasive Travelers' Diarrhea, Hepatic Encephalopathy
Description:
Rifaximin is a non-systemic, broad-spectrum antibiotic that acts locally in the gastrointestinal tract. It is minimally absorbed into the bloodstream, making it ideal for targeting intestinal infections and gut-related conditions without systemic side effects.
Indications:
Travelers' Diarrhea caused by non-invasive Escherichia coli (E. coli)
Hepatic Encephalopathy as a preventive or adjunct therapy
Irritable Bowel Syndrome with Diarrhea (IBS-D) in adults (additional approved use)
Tags:
- Targets gut infections without systemic absorption
- Reduces ammonia-producing bacteria in liver disease
- Minimal drug resistance due to localized action
- Well-tolerated and low risk of systemic side effects
- Fast relief for non-invasive diarrhea in travelers
Usage Information
Dosage
Travelers’ Diarrhea: 200 mg 3 times daily for 3 days Hepatic Encephalopathy: 550 mg twice daily, long-term Route: Oral Take with or without food Note: Always follow your physician’s prescription for specific conditions.
Side Effects
Common: Flatulence Headache Abdominal pain Nausea Rare/Serious: C. difficile infection (rare) Allergic rash or hypersensitivity Fatigue or dizziness
Contraindications
Known allergy to rifamycin-class antibiotics Diarrhea with fever or blood in stools (suggestive of invasive pathogens) Liver impairment: monitor liver function if used long-term Not recommended for children under 12 years (unless prescribed)
Availability
Rifaximin for Travelers’ Diarrhea Rifaximin Hepatic Encephalopathy treatment Non-absorbable antibiotic for gut infection Gut-selective antibiotic